Clinical significance of persistent iatrogenic atrial septal defect after catheter ablation for atrial fibrillation
Kazuki Shimojo1, Itsuro Morishima1, Yasuhiro Morita1
1Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.
Insights
Persistent iatrogenic atrial septal defect (iASD) after atrial fibrillation ablation is linked to worse outcomes. This complication may indicate a higher risk of cardiovascular mortality and heart failure hospitalization post-procedure.
Area of Science:
- Cardiology
- Medical Devices
- Interventional Cardiology
Background:
- Iatrogenic atrial septal defect (iASD) is a common complication following catheter ablation (CA) for atrial fibrillation (AF).
- The clinical significance and prognostic implications of persistent iASD after AF ablation remain incompletely understood.
Purpose of the Study:
- To investigate the association between persistent iASD and AF recurrence.
- To evaluate the relationship of persistent iASD with major adverse clinical outcomes after AF ablation in a comprehensive cohort and a specific subgroup.
Main Methods:
- Retrospective analysis of 1,288 patients undergoing first-time CA for AF (2012-2022).
- Transthoracic echocardiography performed pre-ablation and 3 months post-ablation to assess iASD.
- Evaluation of a subgroup (n=578) using contact force radiofrequency ablation with a standardized two-sheath transseptal approach.
Main Results:
- Persistent iASD was detected in 9.9% of patients.
- Unadjusted analysis showed higher AF recurrence in patients with iASD (p=0.002 overall, p=0.004 subgroup), but this was not significant after multivariable adjustment.
- Persistent iASD was associated with increased cardiovascular mortality (p=0.02) and heart failure hospitalization (p<0.001), particularly in the early phase post-ablation. Ischemic stroke risk was not significantly different (p=0.28).
Conclusions:
- Persistent iASD after AF ablation is linked to increased cardiovascular mortality and early heart failure hospitalizations.
- While not independently predicting AF recurrence in multivariable analysis, persistent iASD may serve as a valuable clinical marker for adverse prognosis following AF ablation.
Background:
Iatrogenic atrial septal defect (iASD) is a frequent complication of catheter ablation (CA) for atrial fibrillation (AF); however, its clinical significance remains unclear.
Objective:
This study investigated the association of persistent iASD with AF recurrence and major clinical outcomes after AF ablation in an overall cohort and a predefined subgroup.
Methods:
This retrospective study included 1288 consecutive patients who underwent first-time CA for AF at Ogaki Municipal Hospital from 2012 to 2022, with transthoracic echocardiography performed before and 3 months after ablation. A predefined subgroup of 578 patients who underwent contact force-sensing radiofrequency ablation using a standardized two-sheath approach with an ablation catheter and a circular mapping catheter was also evaluated. Study outcomes included AF recurrence, all-cause mortality, cardiovascular mortality, heart failure (HF) hospitalization, and ischemic stroke.
Results:
iASD was detected in 127 patients (9.9%). In both the overall cohort and the predefined subgroup, patients with iASD had higher AF recurrence on unadjusted analysis (P = .002 and P = .004, respectively), but not after multivariable adjustment. Multivariable analysis identified sheath size and number, body size-related factors, and tricuspid regurgitation peak velocity as independent predictors of persistent iASD. Cardiovascular mortality and HF hospitalization were higher in patients with persistent iASD (P = .02 and P < .001, respectively), with HF events clustering in the early phase (≤6 months), but not ischemic stroke (P = .28).
Conclusion:
Persistent iASD was associated with AF recurrence on unadjusted analysis, cardiovascular mortality, and early-phase HF hospitalization after AF ablation. These findings suggest that persistent iASD may serve as a clinically relevant marker of adverse prognosis after AF ablation.
Related Concept Videos
Cardiac Catheterization II: Right Heart Catheterization
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease I: Introduction
Mitral Stenosis I: Introduction


